Table 1.
Patient characteristics in Covid-19 patients admitted to general ward (non ICU) or ICU.
| Overall |
Non ICU |
ICU |
non ICU vs ICU | ||||
|---|---|---|---|---|---|---|---|
| n | N | n | p | ||||
| Age [years] | 60.69 ± 18.915 | 96 | 60.98 ± 20.12 | 81 | 59.13 ± 10.54 | 15 | ns |
| Females (%) | 36 (37.5) | 96 | 32 (39.5) | 81 | 4 (26.7) | 15 | ns |
| Smoker (%) | 11 (13.4) | 89 | 9 (11.8) | 76 | 2 (15.4) | 13 | ns |
| Allergies (%) | 21 (23.3) | 91 | 17 (22.1) | 77 | 4 (30.8) | 13 | ns |
| Malignant disease (%) | 9 (9.9) | 91 | 9 (11.5) | 78 | 0 (0) | 13 | ns |
| Hypertension (%) | 46 (50.5) | 91 | 38 (48.7) | 78 | 8 (61.5) | 13 | ns |
| Diabetes (%) | 18 (19.8) | 91 | 15 (19.2) | 78 | 3 (23.1) | 13 | ns |
| Chronic liver disease*,** (%) | 8 (8.8) | 91 | 5 (6.4) | 78 | 3 (23.1) | 13 | ns |
| Heart disease (%) | 20 (122.2) | 90 | 18 (23.4) | 77 | 2 (15.3) | 13 | ns |
| Pulmonary disease (%) | 10 (11) | 91 | 7 (9) | 78 | 3 (12.1) | 13 | ns |
| Immunosuppression (%) | 3 (3.3) | 90 | 1 (1.3) | 77 | 2 (15.4) | 13 | ns |
| Fever >37,3°C (%) | 69 (75.8) | 91 | 56 (71.8) | 78 | 13 (100) | 13 | 0.033 |
| Dyspnea (%) | 45 (50) | 90 | 34 (44.2) | 77 | 11 (84.6) | 13 | 0.014 |
| Cough (%) | 80 (88.9) | 90 | 68 (88.3) | 77 | 12 (92.3) | 13 | ns |
| Sputum (%) | 24 (26.7) | 90 | 22 (28.6) | 77 | 2 (13.3) | 13 | ns |
| Hemoptysis (%) | 5 (5.6) | 89 | 5 (6.5) | 77 | 0 (0) | 13 | ns |
| Sore throat (%) | 26 (28.9) | 90 | 23 (29.9) | 77 | 3 (23.1) | 13 | ns |
| Nasal obstruction (%) | 18 (20) | 90 | 15 (19.5) | 77 | 3 (23.1) | 13 | ns |
| Muscle ache (%) | 60 (66.7) | 90 | 50 (64.9) | 77 | 10 (76.9) | 13 | ns |
| Fatigue (%) | 61 (67.8) | 90 | 51 (66.2) | 77 | 10 (76.9) | 13 | ns |
| Nausea (%) | 14 (15.6) | 90 | 13 (16.9) | 77 | 1 (7.7) | 13 | ns |
| Vomiting (%) | 7 (7.8) | 90 | 7 (9.1) | 77 | 0 (0) | 13 | ns |
| Diarrhea (%) | 16 (17.8) | 90 | 14 (18.2) | 77 | 2 (15.4) | 13 | ns |
| Imaging finding (%) | 55 (61.8) | 89 | 43 (56.6) | 76 | 12 (92.3) | 13 | 0.012 |
| Antibiotic therapy on admisson day (%) | 14 (15.7) | 89 | 11 (14.5) | 76 | 3 (23.1) | 13 | ns |
| Antiviral therapy on admisson day (%) | 1 (1.2) | 86 | 1 (1.4) | 73 | 0 (0) | 13 | ns |
| Antibiotic therapy during hospital stay (%) | 59 (66.3) | 89 | 46 (60.5) | 76 | 13 (100) | 13 | 0.04 |
| Antiviral therapy during hospital stay (%) | 30 (34.5) | 87 | 17 (23) | 74 | 13 (100) | 13 | <0.001 |
| Elevated AST | 41 (42.7) | 96 | 32 (39.5) | 81 | 9 (60) | 15 | ns |
| Hospital stay (days) | 19.4 ± 7.2 | 96 | 8.7 ± 6.3 | 81 | 36.2 ± 15.7 | 15 | <0.001 |
| ICU stay (days) | 24 ± 13.2 | 96 | 0 | 81 | 24 ± 13.2 | 15 | <0.001 |
| Mortality | 7 (7.3) | 96 | 5 (6.2) | 81 | 2 (15.4) | 15 | 0.04 |
**MAFLD (n=6) **chronic hepatitis B infection (n=2).
Patient characteristics in Covid-19 patients admitted to general ward (non ICU) or ICU. Data are expressed as case numbers (percentage) or mean ± standard deviation. AST, aspartate aminotransferase; ICU, intensive care unit; MAFLD, metabolic associated fatty liver disease.